Contact info : [email protected] In recent years, glucagon-like peptide-1 receptor agonists (GLP-1 RAs) use has increased 700% in the general population and over one quarter of those diagnosed with diabetes are on these medications
To date, name brand manufacturers of FDA-approved GLP-1 drugs have not appeared to target compounding pharmacies with patent infringement lawsuits, choosing instead to litigate other claims against these entities, as discussed in more detail above
We are now able to offer affordable pricing for injectable Semaglutide compounded in an FDA Approved compounding pharmacy for as little as $75 $125 per week
It was only in the early 1990s that researchers first infused GLP-1 intravenously in a clinical trial
Bulk and customization available
The test consists of 16 taste strips consisting of 4 different concentrations of sweet, 4 different concentrations of sour, 4 different concentrations of salty and 4 different concentrations of bitter substances
